Table III.
Clinical variables associated with side-specific EPE†
| Parameter | Analysis | |||
|---|---|---|---|---|
| Univariate | Multivariate | |||
| OR | P-value | OR | P-value | |
| PSA | 1.04 | 0.0032** | 1.12 | 0.0081** |
| PSAD | 2.30 | 0.0216* | – | – |
| GS in biopsy | 1.07 | 0.0008*** | 1.72 | 0.0720$ |
| cT in DRE | 1.71 | 0.0483* | 1.08 | 0.8310 |
| PI-RADS (≤ 4 vs. 5) | 3.31 | 0.0001*** | 3.40 | 0.0038** |
| iT in mpMRI | 1.22 | 0.0126* | 1.03 | 0.9509 |
p < 0.1
p < 0.05
p < 0.01
p < 0.001. – Not included in the multivariate model because it is a combination of other variables. PCa – prostate cancer, OR – odds ratio, PSA – prostate-specific antigen, PSAD – prostate-specific antigen density, DRE – digital rectal examination, PI-RADS – Prostate Imaging Reporting and Data System, mpMRI – multiparametric magnetic resonance imaging.
Per side analysis.